Central Clinical Hospital and Polyclinic

Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma

Brian I. Rini, Elizabeth R. Plimack, V.P. Stus et al. · New England Journal of Medicine · 2019 · 3.3K citations · Full text

Pembrolizumab plus axitinib versus sunitinib monotherapy as first-line treatment of advanced renal cell carcinoma (KEYNOTE-426): extended follow-up from a randomised, open-label, phase 3 trial

Thomas Powles, Elizabeth R. Plimack, Denis Soulières et al. · The Lancet Oncology · 2020 · 721 citations

Urology, Oncology, Genitourinary Cancer +6

AVIFAVIR for Treatment of Patients With Moderate Coronavirus Disease 2019 (COVID-19): Interim Results of a Phase II/III Multicenter Randomized Clinical Trial

Andrey A. Ivashchenko, Kirill Dmitriev, Natalia Vostokova et al. · Clinical Infectious Diseases · 2020 · 258 citations · Full text

May 2020, Russian Ministry, Viral Diagnostics +12

Blackout Prevention in the United States, Europe, and Russia

Yuri V. Makarov, Viktor I. Reshetov, A. Stroev et al. · Proceedings of the IEEE · 2005 · 226 citations

Engineering, United Power System, United States +16

Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial

Meinolf Karthaus, Albrecht Kretzschmar, H. Kröning et al. · Annals of Oncology · 2005 · 219 citations · Full text

Venous Disease, Oncology, Venous Thrombosis +10